The board of directors of AID Life Science Holdings Limited announced the following changes regarding the Board: Mr. Wu King Shiu, Kelvin has resigned as the Chairman of the company and a non-executive Director and ceased to act as the chairman of the nomination committee and a member of the remuneration committee of the company with effect from 1 June 2020 in order to devote more time to his personal businesses. Ms. Qian Alexandra Gaochuan has resigned as an executive Director and ceased to act as a compliance officer of the company pursuant to Rule 5.19 of The Rules Governing the Listing of Securities on GEM of The Stock Exchange of Hong Kong Limited, and an authorised representative of the company pursuant to Rule 5.24 of the GEM Listing Rules, all with effect from 1 June 2020 in order to devote more time to her personal businesses. The company also announced that Mr. Hu Kenneth, an executive Director of the company, has been appointed as a member of the Remuneration Committee, the Compliance Officer and the Authorized Representative of the Company with effect from 1 June 2020. Ms. Chan Suet Ngan, an executive Director, the Company Secretary and the Authorized Representative of the Company, has been appointed as the chairman of the Nomination Committee with effect from 1 June 2020. Withdrawal of Resolution Numbered 2(ii) at the annual general meeting: References are made to the circular of the company and the notice of the annual general meeting both dated 12 May 2020 and the form of proxy of the company in relation to the annual general meeting. Due to the resignation of Ms. Qian, ordinary resolution numbered 2(ii) in respect of the re-election of Ms. Qian as an executive Director as set out in the Notice and the Proxy Form are no longer applicable and will not be put forward for consideration and approval by the Shareholders at the AGM. The sequence of the other resolutions and matters in relation to the AGM will remain unchanged.